Clinical Trial Update: Epoprostenol for Injection (EFI/ACT-385781A) - Pulmonary Arterial Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for epoprostenol for injection (EFI/ACT-385781A) in pulmonary arterial hypertension; the study completed and results were posted o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Epoprostenol for Injection (EFI/ACT-385781A) (epoprostenol)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2015-01-13